Cleared Traditional

K151988 - Visible Patient Suite

K151988 is an FDA 510(k) clearance for Visible Patient Suite, manufactured by Visible Patient, Sas. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K151988 · Visible Patient, Sas · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
90d
Days
Class 2
Risk

K151988 is an FDA 510(k) clearance for the Visible Patient Suite. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Visible Patient, Sas (Strasbourg, FR). The FDA issued a Cleared decision on October 15, 2015 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Visible Patient, Sas devices

FDA 510(k) Submission Details - K151988

510(k) Number K151988 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 17, 2015
Decision Date October 15, 2015
Days to Decision 90 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 107d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Hogan Lovells US LLP
JOHN J. SMITH

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2132
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K151988.
UroNav (Version 2.0)
K153073 · Invivo Corporation · Nov 2015
Ziostation2
K151212 · Qi Imaging, LLC · Nov 2015
Volpara Imaging Software
K152028 · Matakina Technologies Limited · Oct 2015
DEXIS Webview
K151941 · Imaging Sciences International /Gendex/Dexis · Oct 2015
OrthoVis Web Portal
K151501 · Custom Orthopaedic Solutions, Inc. · Oct 2015
CARESTREAM Vue Motion
K151774 · Carestream Health, Inc. · Sep 2015